title: Breast cancer drug appears to extend patients' lives by 15 months.
authors.affiliation: Kaiser Permanente Oakland Medical Center, CA, USA.
authors.forename: Deborah
authors.initials: D
authors.lastname: McBride
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000401:mortality; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; C485206:pertuzumab; D000068878:Trastuzumab